BioAdvance ^Investors

BioAdvance is a venture capital firm based in Pennsylvania that specializes in funding life sciences startups. With their $50 million Greenhouse Fund, they invest in companies focused on therapeutics, devices, diagnostics, and platform technologies for human health. Since their establishment in 2003, BioAdvance has committed over $40 million to more than 50 seed-stage companies and 17 pre-seed companies. Their portfolio includes companies working on innovative solutions for health issues such as Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was initially funded with $33 million from Pennsylvania's tobacco settlement monies.